PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT • 2.1 Preface • 2.2 Preface • 2.3 Currency conversion rates for US$ PART 03: MARKET LANDSCAPE • Market ecosystem • Market characteristics • Market segmentation analysis PART 04: MARKET SIZING • Market definition • Market sizing 2018 • Market size and forecast 2018-2023 PART 05: FIVE FORCES ANALYSIS • Bargaining power of buyers • Bargaining power of suppliers • Threat of new entrants • Threat of substitutes • Threat of rivalry • Market condition PART 06: MARKET SEGMENTATION BY PRODUCT • Market segmentation by product • Comparison by product • Consumables - Market size and forecast 2018-2023 • Instruments - Market size and forecast 2018-2023 • Software - Market size and forecast 2018-2023 • Market opportunity by product PART 07: CUSTOMER LANDSCAPE PART 08: GEOGRAPHIC LANDSCAPE • Geographic segmentation • Geographic comparison • North America - Market size and forecast 2018-2023 • Europe - Market size and forecast 2018-2023 • Asia - Market size and forecast 2018-2023 • ROW - Market size and forecast 2018-2023 • Key leading countries • Market opportunity PART 09: DRIVERS AND CHALLENGES • Market drivers • Market challenges PART 10: MARKET TRENDS • Technological advances focusing on advanced techniques and automated systems • Increasing government support pertaining to blood safety • Growing demand for blood transfusions and blood group typing PART 11: VENDOR LANDSCAPE • Overview • Landscape disruption PART 12: VENDOR ANALYSIS • Vendors covered • Vendor classification • Market positioning of vendors • Agena Bioscience • Bio-Rad Laboratories • Danaher • Merck KGaA • Ortho Clinical Diagnostics PART 13: APPENDIX • Research methodology • List of abbreviations   Exhibit 01: Years in consideration Exhibit 02: Global medical devices market Exhibit 03: Segments of global medical devices market Exhibit 04: Market characteristics Exhibit 05: Market segments Exhibit 06: Market definition - Inclusions and exclusions checklist Exhibit 07: Market size 2018 Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions) Exhibit 09: Global market: Year-over-year growth 2019-2023 (%) Exhibit 10: Five forces analysis 2018 Exhibit 11: Five forces analysis 2023 Exhibit 12: Bargaining power of buyers Exhibit 13: Bargaining power of suppliers Exhibit 14: Threat of new entrants Exhibit 15: Threat of substitutes Exhibit 16: Threat of rivalry Exhibit 17: Market condition - Five forces 2018 Exhibit 18: Product - Market share 2018-2023 (%) Exhibit 19: Comparison by product Exhibit 20: Consumables - Market size and forecast 2018-2023 ($ millions) Exhibit 21: Consumables - Year-over-year growth 2019-2023 (%) Exhibit 22: Instruments - Market size and forecast 2018-2023 ($ millions) Exhibit 23: Instruments - Year-over-year growth 2019-2023 (%) Exhibit 24: Software - Market size and forecast 2018-2023 ($ millions) Exhibit 25: Software - Year-over-year growth 2019-2023 (%) Exhibit 26: Market opportunity by product Exhibit 27: Customer landscape Exhibit 28: Market share by geography 2018-2023 (%) Exhibit 29: Geographic comparison Exhibit 30: North America - Market size and forecast 2018-2023 ($ millions) Exhibit 31: North America - Year-over-year growth 2019-2023 (%) Exhibit 32: Europe - Market size and forecast 2018-2023 ($ millions) Exhibit 33: Europe - Year-over-year growth 2019-2023 (%) Exhibit 34: Asia - Market size and forecast 2018-2023 ($ millions) Exhibit 35: Asia - Year-over-year growth 2019-2023 (%) Exhibit 36: ROW - Market size and forecast 2018-2023 ($ millions) Exhibit 37: ROW - Year-over-year growth 2019-2023 (%) Exhibit 38: Key leading countries Exhibit 39: Market opportunity Exhibit 40: Decision framework Exhibit 41: Impact of drivers and challenges Exhibit 42: Vendor landscape Exhibit 43: Landscape disruption Exhibit 44: Vendors covered Exhibit 45: Vendor classification Exhibit 46: Market positioning of vendors Exhibit 47: Agena Bioscience - Vendor overview Exhibit 48: Agena Bioscience - Business segments Exhibit 49: Agena Bioscience - Organizational developments Exhibit 50: Agena Bioscience - Key offerings Exhibit 51: Bio-Rad Laboratories - Vendor overview Exhibit 52: Bio-Rad Laboratories - Business segments Exhibit 53: Bio-Rad Laboratories - Organizational developments Exhibit 54: Bio-Rad Laboratories - Geographic focus Exhibit 55: Bio-Rad Laboratories - Segment focus Exhibit 56: Bio-Rad Laboratories - Key offerings Exhibit 57: Danaher - Vendor overview Exhibit 58: Danaher - Business segments Exhibit 59: Danaher - Organizational developments Exhibit 60: Danaher - Geographic focus Exhibit 61: Danaher - Segment focus Exhibit 62: Danaher - Key offerings Exhibit 63: Merck KGaA - Vendor overview Exhibit 64: Merck KGaA - Product segments Exhibit 65: Merck KGaA - Organizational developments Exhibit 66: Merck KGaA - Geographic focus Exhibit 67: Merck KGaA - Segment focus Exhibit 68: Merck KGaA - Key offerings Exhibit 69: Ortho Clinical Diagnostics - Vendor overview Exhibit 70: Ortho Clinical Diagnostics - Business segments Exhibit 71: Ortho Clinical Diagnostics - Organizational developments Exhibit 72: Ortho Clinical Diagnostics - Key offerings Exhibit 73: Validation techniques employed for market sizing Exhibit 74: List of abbreviations    

Agena Bioscience Bio-Rad Laboratories Danaher Merck KGaA Ortho Clinical Diagnostics